Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | 0 | uM | 7 | 156.25 | 33.46 | 100.00 | 96.25 | 1.0390 | 1.0508 | |
| SK-BR-3 | Erlotinib | 10 | uM | 7 | 156.25 | 33.46 | 77.00 | 96.25 | 0.8000 | 0.7277 |
| SK-BR-3 | Erlotinib | 0.01 | uM | 7 | 156.25 | 33.46 | 165.00 | 96.25 | 1.7143 | 1.8483 |
| SK-BR-3 | Lapatinib | 10 | uM | 7 | 156.25 | 33.46 | 81.00 | 96.25 | 0.8416 | 0.7860 |
| SK-BR-3 | Linsitinib | 19.9526 | uM | 7 | 156.25 | 33.46 | 125.00 | 96.25 | 1.2987 | 1.3741 |
| SK-BR-3 | Erlotinib | 0.0033113 | uM | 7 | 156.25 | 33.46 | 136.00 | 96.25 | 1.4130 | 1.5091 |
| SK-BR-3 | Erlotinib | 0.031623 | uM | 7 | 156.25 | 33.46 | 120.00 | 96.25 | 1.2468 | 1.3113 |
| SK-BR-3 | Lapatinib | 1 | uM | 7 | 156.25 | 33.46 | 134.00 | 96.25 | 1.3922 | 1.4848 |
| SK-BR-3 | 17-AAG | 0.1 | uM | 7 | 156.25 | 33.46 | 57.00 | 96.25 | 0.5922 | 0.4183 |
| SK-BR-3 | Lapatinib | 0.01 | uM | 7 | 156.25 | 33.46 | 80.00 | 96.25 | 0.8312 | 0.7715 |
| SK-BR-3 | 0 | uM | 7 | 156.25 | 33.46 | 111.00 | 96.25 | 1.1532 | 1.1961 | |
| SK-BR-3 | 0 | uM | 7 | 156.25 | 33.46 | 2.00 | 96.25 | 0.0208 | -0.8425 | |
| SK-BR-3 | 0 | uM | 7 | 312.50 | 169.63 | 2.00 | 280.00 | 0.0071 | -0.9979 | |
| SK-BR-3 | 0 | uM | 7 | 312.50 | 169.63 | 195.00 | 280.00 | 0.6964 | 0.2126 | |
| SK-BR-3 | 0 | uM | 7 | 312.50 | 169.63 | 267.00 | 280.00 | 0.9536 | 0.8727 | |
| SK-BR-3 | 17-AAG | 3.1623 | uM | 7 | 312.50 | 169.63 | 134.00 | 280.00 | 0.4786 | -0.2782 |
| SK-BR-3 | Lapatinib | 0.0033113 | uM | 7 | 312.50 | 169.63 | 267.00 | 280.00 | 0.9536 | 0.8727 |
| SK-BR-3 | Lapatinib | 0.031623 | uM | 7 | 312.50 | 169.63 | 207.00 | 280.00 | 0.7393 | 0.3170 |
| SK-BR-3 | 17-AAG | 0.0033113 | uM | 7 | 312.50 | 169.63 | 145.00 | 280.00 | 0.5179 | -0.1950 |
| SK-BR-3 | Linsitinib | 1 | uM | 7 | 312.50 | 169.63 | 309.00 | 280.00 | 1.1036 | 1.2920 |
| SK-BR-3 | Lapatinib | 0.0016596 | uM | 7 | 312.50 | 169.63 | 317.00 | 280.00 | 1.1321 | 1.3745 |
| SK-BR-3 | 0 | uM | 7 | 312.50 | 169.63 | 399.00 | 280.00 | 1.4250 | 2.2640 | |
| SK-BR-3 | Linsitinib | 0.0033113 | uM | 7 | 312.50 | 169.63 | 439.00 | 280.00 | 1.5679 | 2.7251 |
| SK-BR-3 | Linsitinib | 0.1 | uM | 7 | 312.50 | 169.63 | 321.00 | 280.00 | 1.1464 | 1.4160 |
| SK-BR-3 | Lapatinib | 0.31623 | uM | 7 | 312.50 | 169.63 | 244.00 | 280.00 | 0.8714 | 0.6534 |